Xeon International Nominated as Promicol Licensing Fund Manager

Xeon International, a leading investment management firm, is pleased to announce its nomination as the Promicol Licensing Fund Manager.

The Promicol Licensing Fund is an innovative investment vehicle focused on identifying and investing in promising technology licensing opportunities. Through its unique approach, the fund aims to generate attractive returns for investors while supporting the development and commercialization of breakthrough technologies.

Xeon International’s deep expertise in investment management and its track record of success in identifying and investing in high-potential opportunities make it an ideal choice to manage the Promicol Licensing Fund. The firm’s experienced team of professionals will leverage their knowledge and networks to identify and evaluate potential investments, ensuring that the fund is well-positioned to capture the most promising licensing opportunities.

“We are honored to have been nominated as the Promicol Licensing Fund Manager,” said Mr. Yves Duponselle, CEO of Xeon International. “We believe that the fund’s unique focus on technology licensing offers an exciting opportunity for investors to participate in the growth and development of breakthrough technologies. Especially the future early detection of Cancer will be a game changer.

Our team is looking forward to leveraging our expertise to identify and invest in the most promising opportunities.”

The Promicol Licensing Fund is now open for investment, and Xeon International is actively seeking investors/ Licensees who are interested in participating in this innovative investment opportunity. For more information on the fund and how to invest, please contact Xeon International at info@xeon-international.com

About Promicol: Promicol B.V. is a Dutch biotech company that has been making significant
strides in the field of microbiological quality control. With a focus on providing
fast and accurate testing solutions, the company has been able to attract a diverse
range of clients, including large pharmaceutical companies, food manufacturers,
and research organizations.

About Xeon International: Xeon International is a leading investment management firm that offers a wide range of investment solutions to institutional and individual investors. With offices around the world, the firm has a global reach and a deep understanding of local markets. Xeon International is committed to delivering innovative investment solutions that help its clients achieve their financial goals.

Contact: Ben Kee – Managing Director – Xeon International Singapore – bk@xeon-international.com